ABCB1 and non-small cell lung carcinoma: Shuai Peng et al. demonstrated that emodin (5 μM) enhanced H460 and A549 cell sensitivity to cisplatin through P-glycoprotein downregulation in non-small cell lung cancer (NSCLC) [219].